Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
CD Protein Inhibitors
«
1
2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
11
22
33
44
55
66
77
88
99
110
Puyouheng
(pucotenlimab) / Taizhou Hanzhong Biopharma, Lepu Med
Rituxan Hycela
(rituximab/hyaluronidase) / Biogen, Roche, Halozyme
TQB3616
/ Sino Biopharm
Truxima
(rituximab-abbs) / Indukern, Teva, Mundipharma, Celltrion, Nippon Kayaku
VG161
/ ViroGin Biotech
emactuzumab
(RG7155) / SynOx Therap
enoblituzumab
(MGA271) / MacroGenics
lorvotuzumab mertansine
(IMGN901) / AbbVie
magrolimab
(ONO-7913) / Ono Pharma
mupadolimab
(CPI-006) / Corvus Pharma
oleclumab
(MEDI9447) / AstraZeneca
ontorpacept
(PF-07901800) / Pfizer
orlotamab
(MGD009) / MacroGenics
pidilizumab
(CT-011) / CureTech
pradusinstobart
(LVGN3616) / Lyvgen
rhIL-15
/ National Cancer Institute
sotigalimab
(PYX-107) / Pyxis Oncology
tidutamab
(XmAb18087) / Xencor
urelumab
(BMS-663513) / BMS, Ono Pharma
volrustomig
(MEDI5752) / AstraZeneca
zeluvalimab
(AMG 404) / Amgen
«
1
2
